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Addendum to: 
NF-kB Activation Represses TNF-a-Induced Autophagy

ABstrACt
The NFkB transcription factor is an important anti-apoptotic factor, which is frequently deregulated in cancer cells. We have recently demonstrated that NFkB activation mediates the repression of autophagy in response to TNFa in three models of cancer cell lines. In contrast, in the absence of NFkB activation, TNFa induces macroautophagy (autophagy), which requires reactive oxygen species (ROS) production and participates in the TNFa-induced apoptotic signaling pathway. Autophagy-dependent apoptosis was also observed following direct addition of ROS to cells. Moreover, addition of rapamycin to TNFa renders these cells susceptible to the cytotoxic effect of this cytokine. These findings highlight the regulation of autophagy by oxidative stress and support the idea that repression of autophagy by NFkB may constitute a novel anti-apoptotic function of this transcription factor. We also bring evidence that direct stimulation of autophagy may represent a new therapeutic strategy for overcoming the NFkB-dependent chemoresistance of cancer cells.
InACtIvAtIon oF nFkB ACtIvAtes AutoPhAgy In tnFa-treAteD Cells
NFkB is now widely recognized as a major culprit in cancer. 1 This transcription factor activates genes whose products are involved in several tumor-promoting signals including those that favor cell survival, metastasis and pro-inflammatory responses. 2 Autophagy is another mechanism involved in the control of cancer 3 but little is known about its modulation by apoptosis-regulatory factors.
We investigated whether NFkB, which is a key regulator of apoptosis, modulates autophagy. For this purpose, we compared autophagic activity in response to TNFa, an efficient stimulator of NFkB activation, in NFkB-competent cells versus cells carrying a repressor of NFkB activity. We observed that, in cell lines derived from three types of cancer (Ewing sarcoma, breast cancer and acute promyelocytic leukemia), TNFa-induced NFkB activation causes repression of autophagy. 4 In accordance with our results, it has been recently reported that inhibition of NFkB results in an enhancement of starvation-induced autophagy. 5 Nevertheless, the mechanism involved in such NFkB-mediated repression of autophagy remains largely unknown. One possibility is an NFkB-dependent stimulation of the mTOR pathway which is known to negatively regulate autophagy. 6 This hypothesis is based on our observation that mTOR activity is induced by TNFa but only in NFkB-competent cells. 4 Another possibility is a modulation of the Beclin 1/Bcl-2 balance by NFkB since Bcl-2 can control autophagy by interacting with Beclin 1, 7 and NFkB can regulate Bcl-2 levels. 8 Interestingly, recent studies provided evidence that, in turn, NFkB activity can be modulated by autophagy-related signaling. Indeed, NFkB activity is positively regulated by an inhibitor of the mTOR pathway, TSC2. 9 Inversely, the IkB kinase, an upstream activator of NFkB, was shown to be degraded by autophagy following loss of Hsp90 function 10 supporting that, in certain conditions, NFkB activity can be negatively regulated by autophagy. Such a repression of NFkB activity by autophagy may constitute an amplifying loop of cell death since both apoptosis and autophagy are inhibited by this transcription factor.
regulAtIon oF AutoPhAgy By nFkB Is A reDox-sensItIve MeChAnIsM
We and others have previously shown that inhibition of NFkB activation results in increased ROS production in TNFa-treated cells. 11, 12 We found that this accumulation NFkB, ROS and Autophagy of ROS is responsible of the induction of autophagy in TNFatreated cells carrying a repressor of NFkB activation. In addition, we provide evidence that direct addition of exogenous ROS is also able to induce autophagy in these cells.Consistent with these observations, both TNFa and ROS induce an increase in Beclin 1 expression. Moreover, rapamycin-induced autophagy is accompanied by ROS accumulation and lipid peroxidation in yeast 13 and ROS accumulation is required for starvation-induced autophagy. 14 Inversely, it has been shown that autophagy can regulate ROS metabolism: Z-VAD-FMK (benzyloxycarbonyl-val-Ala-Asp(Ome)-fluoromethylketone), a broad spectrum caspase inhibitor causes selective autophagic degradation of catalase, one of the major antioxidants, leading to intracellular ROS accumulation. 15 Also, in cells carrying a repressor of NFkB activation, we have observed that autophagy contributes to ROS accumulation induced by TNFa (data not shown). These findings demonstrate that autophagy and ROS metabolism regulate each other.
AutoPhAgy ContrIButes to the InDuCtIon oF APoPtosIs In tnFa-treAteD Cells
The involvement of autophagy in the apoptotic pathway has recently been a subject of debate. Under certain stress conditions, autophagy displays an anti-apoptotic function, whereas recent findings support a pro-apoptotic role for this process. 3 We found that knockdown of autophagy effectors with small interfering RNAs reduced TNFa-induced apoptosis in cells carrying a repressor of NFkB activation. A similar effect was observed in both NFkBcompetent and NFkB-incompetent cells treated with exogeneous ROS. These results indicate that autophagy participates in the apoptotic signaling pathway induced by these compounds. These observations prompted us to investigate whether direct induction of autophagy could sensitize NFkB-competent cells to TNFa-induced apoptosis. For this purpose, cells were pretreated with rapamycin (a well-known activator of autophagy) prior to addition of TNFa. As shown in Figure 1 , although NFkB-competent cells are completely resistant to the cytotoxic effect of TNFa, the addition of rapamycin induced an accumulation of autophagic vacuoles and rendered these cells susceptible to the cytotoxic effect of TNFa. Of note, TNFa treatment reduced the stimulation of autophagy induced by rapamycin which is in accordance with our result showing that NFkB activation by TNFa inhibited autophagy. 4 It is worth nothing that rapamycin, when used alone, did not increase the percentage of apoptotic cells. These results suggest that autophagy amplifies apoptosis when associated with a death receptor signaling pathway. One possible mechanism involved in such a pro-apoptotic effect of autophagy induced by rapamycin may be mediated, at least in part, by the inhibition of NFkB activity by this agent.
ConClusIon
Altogether, these findings delineate the crosstalk between autophagy, NFkB and ROS ( Fig. 2 ) and raise the question as to whether inducers of autophagy (rapamycin and its analogues) can be used in combination with anti-cancer therapies that activate NFkB in order to improve their effectiveness.
